Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
about
Safety and efficacy of azacitidine in myelodysplastic syndromesThe role of dicer in DNA damage repairNKG2D and DNAM-1 Ligands: Molecular Targets for NK Cell-Mediated Immunotherapeutic Intervention in Multiple MyelomaMyelodysplastic syndromes: the role of the immune system in pathogenesis.Low-dose azacitidine after allogeneic stem cell transplantation for acute leukemiaMHC class I-related chain A and B ligands are differentially expressed in human cervical cancer cell linesDecitabine enhances anti-CD33 monoclonal antibody BI 836858-mediated natural killer ADCC against AML blastsCombination treatment with decitabine and ionizing radiation enhances tumor cells susceptibility of T cellsNatural Killer Group 2, Member D/NKG2D Ligands in Hematopoietic Cell Transplantation.Natural killer cells and malignant haemopathies: a model for the interaction of cancer with innate immunity.Prostate cancer and immunoproteome: awakening and reprogramming the guardian angels.Hematological malignancies escape from NK cell innate immune surveillance: mechanisms and therapeutic implications.Novel immune modulators used in hematology: impact on NK cellsGeneration of soluble NKG2D ligands: proteolytic cleavage, exosome secretion and functional implications.Regulation of self-ligands for activating natural killer cell receptors.Epigenetic therapy in allogeneic hematopoietic stem cell transplantation.The DNA Damage Response: A Common Pathway in the Regulation of NKG2D and DNAM-1 Ligand Expression in Normal, Infected, and Cancer Cells.NKG2D signaling in cancer immunosurveillance.Cancer-Induced Alterations of NK-Mediated Target Recognition: Current and Investigational Pharmacological Strategies Aiming at Restoring NK-Mediated Anti-Tumor ActivityImproving cancer immunotherapy with DNA methyltransferase inhibitors.Methylation of NKG2D ligands contributes to immune system evasion in acute myeloid leukemia.Azacytidine impairs NK cell reactivity while decitabine augments NK cell responsiveness toward stimulation.RNA-binding proteins regulate the expression of the immune activating ligand MICB.Natural killer cells modulation in hematological malignancies.Natural Killer Cell Response to Chemotherapy-Stressed Cancer Cells: Role in Tumor Immunosurveillance.STAT3 signaling pathway is involved in decitabine induced biological phenotype regulation of acute myeloid leukemia cellsResveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway.Primary B-CLL resistance to NK cell cytotoxicity can be overcome in vitro and in vivo by priming NK cells and monoclonal antibody therapy.Stochastics of Cellular Differentiation Explained by Epigenetics: The Case of T-Cell Differentiation and Functional Plasticity.A phase 1 study of lirilumab (antibody against killer immunoglobulin-like receptor antibody KIR2D; IPH2102) in patients with solid tumors and hematologic malignancies.Decitabine Enhances Vγ9Vδ2 T Cell-Mediated Cytotoxic Effects on Osteosarcoma Cells via the NKG2DL-NKG2D Axis.Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells
P2860
Q24596561-0A6E4619-1DC2-43C1-A84C-CB862EBDCB40Q24632764-89827408-AF35-466F-8C04-D06B523A81D2Q28080823-D82038C2-32C9-4B8D-9E76-12B48115DBA1Q33351527-E42C75CD-A093-41D4-94EC-D0A98BD9BA6EQ33861150-88DD7C75-F9C5-49F8-92C9-2749A1EB42FDQ35061364-BEFDFA75-C9FF-455F-BED9-3C637C0799F4Q36989586-74FE2083-7906-4413-BDD8-849AAA4C7C55Q37285301-187E614F-0DA8-418A-AF17-2B09671498A5Q37721591-6472C152-C4BB-402F-8E86-CAD8EFCE1150Q37779043-1C906698-8CD9-493D-BD98-826165019B25Q38000961-2DBA02EB-6FE1-4729-AC36-1C9C37DD041EQ38035301-C867A4C7-5F28-4CC8-B007-F8B901AF9245Q38073760-3F387613-FC65-4F4B-B931-3D33208AABDBQ38107250-C7678267-70DC-4A1F-826D-E249911537A8Q38108820-3204B96F-1F05-4897-A23C-4B41A2038BA6Q38112417-16CC9083-EA0B-4F8F-A8F8-2C9C9ACAB818Q38178966-C70CFC95-5810-4181-9E7E-61EB8FF43AECQ38194944-85A05322-BAE6-42AC-9CCB-B8CE5E473F72Q38203261-41B2011C-DCE7-44CB-A752-1DEB139B4014Q38662760-9F406452-0BD1-48FF-A6C8-E1014FDD8673Q38940720-BD39AC89-E935-46E0-AB53-48A840A7BDADQ39642001-55A29ADD-F81D-4D04-A24E-FE9963C80D4BQ40919209-27BF0B8C-4C68-44A3-855D-D0A299CA4FB8Q41982546-FC631802-F14A-40A6-B5E6-45C536D627CCQ42042886-D6C8BD3A-39A4-412B-B524-4FC36C46030EQ42250309-6EE5E975-BC1E-44B1-A5D5-700A319B9E69Q42371577-D3D948AC-E25D-4E15-B875-2BBAE44A8B4FQ45009828-3E09ABE4-83E2-4B1B-A6A2-1D8C2BA8FF98Q47965246-AC8218B7-FEB4-4750-8376-6FB157F4240FQ54943618-00EF467F-E721-42F7-909A-7997CA4C5C5EQ55279130-E0905568-F83B-4815-A77C-3AC9CC44FA9AQ58143382-F9471E0A-0748-4320-AE53-A38344F5DA2C
P2860
Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
@en
Induction of MHC class I-related chain B
@nl
type
label
Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
@en
Induction of MHC class I-related chain B
@nl
prefLabel
Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
@en
Induction of MHC class I-related chain B
@nl
P2093
P1476
Induction of MHC class I-related chain B (MICB) by 5-aza-2'-deoxycytidine.
@en
P2093
Ai-Long Huang
Cai-Xia He
Guan-Bin Song
Gui-Li Zeng
Jinfeng Wu
Kai-Fu Tang
Wei-Guang Zhang
Yi-Song Shi
P304
P356
10.1016/J.BBRC.2008.03.131
P577
2008-04-04T00:00:00Z